Commercial insurance still varies: coverage is common for type 2 diabetes, less consistent for weight loss alone
I don't see [GLP-1 agonists] as being any different than other medicine that we use to treat chronic conditions like atherosclerotic heart disease. While the data are not clear about the maintenance of CV benefits in those going off GLP-1 agents, data from mixed diet and lifestyle intervention studies, for example, do suggest that the cardiometabolic benefits of the lost weight may persist out to 5 years, even if some is regained
Guan ZX, Jin Z, Guan S, Liu K, Tao L, Luo
According to company terms of use: "MEDVi does not provide any Healthcare Services through the Platform and is not licensed to practice medicine." This legal structure separates platform technology from clinical decision-making authority, which rests with independent licensed medical providers
I see LIPO batteries specify a C rating on the label
Lyophilized Storage: Store at -20C in a dry, moisture-free environment